MORF Morphic Holding, Inc.

Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.

$21.38  -1.27 (-5.59%)
As of 06/28/2022 14:55:28 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  06/27/2019
Outstanding shares:  38,269,371
Average volume:  373,178
Market cap:   $883,257,083
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BK8M4J4
Valuation   (See tab for details)
PE ratio:   -8.35
PB ratio:   2.74
PS ratio:   46.71
Return on equity:   -33.74%
Net income %:   -559.19%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy